Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. Companies
  3. usa california
  4. pre clinical effectiveness case study
Show results for
Products
Companies
Refine by
Locations
Back to All Locations
Business Types
Industries served

Pre Clinical Effectiveness Case Study Technology In Usa California

2 companies found
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Technologybased inSan Diego, CALIFORNIA (USA)
We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19. Cancer is genetically diverse, highly adaptive, constantly mutating and virtually invisible to ...
Model DAR T - Dimeric Antigen Receptor-T Cell

Model DAR T - Dimeric Antigen Receptor-T Cell

Sorrento utilizes a proprietary knock-out knock-in (KOKI) technology to modify normal healthy donor derived T cells to genetically engineer them to express the dimeric antigen receptor into T-cell receptor (TCR) alpha chain constant region ...
CONTACT SUPPLIER
LIXTE Biotechnology Holdings, Inc.

LIXTE Biotechnology Holdings, Inc.

Technologybased inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
Model LB-100 - Hematologic and Solid Tumor Cancers

Model LB-100 - Hematologic and Solid Tumor Cancers

Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and solid tumor cancers without enhancing ...
CONTACT SUPPLIER
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you